作者
Hoorieh Mohammadi Kenari,Masoumeh Teimouri,Fatemeh Askari Yazdian,Yaser Jafari,Gholamreza Kordafshari,Maryam Moghimi,Javad Mohammadnejad
摘要
ABSTRACT Due to the importance of cancer therapy, nowadays, the DNA‐aptamer‐chitosan‐starch hydrogel beads were potentially fabricated for inducing apoptosis and cell cycle arrest on MCF‐7, HCT116, and SKOV3 cancer cells. Padzahr was used as a conventional therapeutic agent for the first time in this research. The hydrogel beads were then characterized through analytical devices including FT‐IR, XRD, DLS, and FE‐SEM. The size was ascertained at 750 nm in diameter with an approximately globular shape, and an 86.4 mV charge was measured for the surface charge. Less than 50% and more than 50% drug loading and encapsulation efficiency were estimated for the hydrogel beads, respectively, which are remarkable values. Controlled drug release manner was attained at pH 7.4 (about 50% drug releases after 40 h) which was more sustained than drug release at pH 5.0. Afterward, the apoptosis and cell cycle arrest tests were conducted for evaluating cancer cell growth inhibition performance of hydrogel beads in vitro. After treatment of cancer cells with drug‐loaded nanogel, apoptosis values were considerably dropped to 13.78%, 16.24%, and 8.8% compared to control for MCF‐7, HCT116, and SKOV3 cells, respectively. Moreover, cell cycle arrest assay results indicated remarkable apoptosis‐inducing amounts, 2 folds, 8 folds, and 3 folds compared with control after treatment with drug‐loaded nanogel in MCF‐7, HCT116, and SKOV3 cells, respectively. These data have demonstrated the potential ability of synthesized nanogel in the suppression of cancer cells and indicated the efficient performance of nanogel as an excellent drug delivery system.